Nonprescription headache remedies save consumers $4.23 bil. annually -- Kline study.
This article was originally published in The Tan Sheet
Executive Summary
Rx-to-OTC SWITCH PRODUCTS SAVED CONSUMERS $12.88 BIL. IN 1996, according to a study conducted by Fairfield, N.J.-based Kline & Company for the Nonprescription Drug Manufacturers Association. Presented at NDMA's May 15-18 annual meeting in White Sulphur Springs, W.Va., the study found that the savings generated by switch products represented 63% of the total savings attributable to OTCs. "It is clear that the Rx-to-OTC switch process contributes greatly to the continued value of OTC products," Kline maintained